UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 30, 2008
MedQuist Inc.
(Exact name of registrant as specified in charter)
| | | | | |
| New Jersey | | 0-19941 | | 22-2531298 |
| |
| (State or other jurisdiction | | (Commission | | (I.R.S. Employer |
| of incorporation) | | File Number) | | Identification No.) |
| | | |
| 1000 Bishops Gate Blvd., Suite 300, Mt. Laurel, NJ | | 08054 |
| |
| (address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (856) 206-4000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | |
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | |
| Item 5.02 | | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| | (b) | | R. Scott Bennett, the Senior Vice President of Sales and Marketing of MedQuist Inc. (the “Company”), left the Company to pursue other opportunities effective October 30, 2008. |
| |
| | (c) | | The board of directors of the Company has appointed Peter Masanotti, the Chief Executive Officer of the Company, as the President and Chief Executive Officer of the Company effective as of November 3, 2008. |
| |
| | | | The terms of Mr. Masanotti’s employment with the Company continue to be governed by the employment agreement the Company entered into with him on September 3, 2008 (the “Employment Agreement”). |
| |
| | | | The current report on Form 8-K filed with the Securities and Exchange Commission on September 9, 2008 is hereby incorporated by reference with respect to the Employment Agreement and other terms of Mr. Masanotti’s employment with the Company discussed therein. |
| | | | There are no transactions in which Mr. Masanotti has an interest requiring disclosure under Item 404(a) of Regulation S-K or any family relationships requiring disclosure under Item 401(d) of Regulation S-K. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | MEDQUIST INC.
| |
| Date: November 5, 2008 | By: | /s/ Mark R. Sullivan | |
| | | Name: | Mark R. Sullivan | |
| | | Title: | General Counsel, Chief Compliance
Officer & Secretary | |
| |
